D.E. Shaw & Co
CELG

D.E. Shaw & Co’s Celgene Corp CELG Stock Holding History

D.E. Shaw & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-405,900
Closed -$40.3M – 4330
2019
Q3 		$40.3M Sell
405,900
-60,000
-13% -$5.7M 0.05% 453
2019
Q2 		$43.1M Sell
465,900
-575,500
-55% -$54.6M 0.05% 426
2019
Q1 		$98.2M Sell
1,041,400
-1,451,700
-58% -$127M 0.13% 192
2018
Q4 		$160M Buy
2,493,100
+297,600
+14% +$22M 0.22% 90
2018
Q3 		$196M Sell
2,195,500
-290,900
-12% -$25.7M 0.24% 78
2018
Q2 		$197M Buy
2,486,400
+580,600
+30% +$48.2M 0.26% 72
2018
Q1 		$170M Buy
1,905,800
+1,318,500
+225% +$127M 0.23% 87
2017
Q4 		$61.3M Buy
587,300
+571,400
+3,594% +$64.5M 0.08% 292
2017
Q3 		$2.32M Sell
15,900
-24,100
-60% -$3.28M ﹤0.01% 1916
2017
Q2 		$5.2M Sell
40,000
-63,300
-61% -$7.76M 0.01% 1304
2017
Q1 		$12.9M Sell
103,300
-250,100
-71% -$29.9M 0.02% 776
2016
Q4 		$40.9M Sell
353,400
-74,600
-17% -$8.31M 0.07% 366
2016
Q3 		$44.7M Buy
428,000
+76,900
+22% +$8.32M 0.08% 311
2016
Q2 		$34.6M Sell
351,100
-170,500
-33% -$17.6M 0.06% 365
2016
Q1 		$52.2M Buy
521,600
+173,200
+50% +$17.8M 0.09% 252
2015
Q4 		$41.7M Sell
348,400
-167,400
-32% -$19.4M 0.06% 366
2015
Q3 		$55.8M Buy
515,800
+47,200
+10% +$5.86M 0.08% 294
2015
Q2 		$54.2M Buy
468,600
+69,100
+17% +$7.9M 0.08% 300
2015
Q1 		$46.1M Sell
399,500
-784,000
-66% -$93.7M 0.07% 330
2014
Q4 		$132M Buy
1,183,500
+113,800
+11% +$12M 0.17% 113
2014
Q3 		$101M Buy
1,069,700
+101,000
+10% +$9.11M 0.13% 167
2014
Q2 		$83.2M Sell
968,700
-334,300
-26% -$25.4M 0.11% 205
2014
Q1 		$90.9M Sell
1,303,000
-258,200
-17% -$20.4M 0.13% 160
2013
Q4 		$132M Buy
1,561,200
+58,200
+4% +$4.61M 0.18% 101
2013
Q3 		$116M Buy
1,503,000
+541,000
+56% +$37.9M 0.18% 97
2013
Q2 		$56.2M Buy
+962,000
New +$57.9M 0.11% 198

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

D.E. Shaw & Co's CELG Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,627,564 shares — an estimated $460M sold.

D.E. Shaw & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $693M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,627,564 Celgene Corp shares in Q4 2019, an estimated $460M.
  • D.E. Shaw & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • D.E. Shaw & Co's Celgene Corp position peaked at $693M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.